Articles

How to win the high-momentum stock game

Momentum stocks have historically beaten the stock market by a large margin — until recently.

Intel’s stock is on a five-day hot streak — but it’s still below last month’s highs

Despite excitement over Intel’s new CEO, shares are still below the company’s year-to-date highs — in February, when investors were expecting an imminent breakup.

Your 401(k) may need some all-weather protection

With retail investors in the grip of stock-market turmoil, a fund that protects against all kinds of financial risks seems like a good idea. Is it?

Home builders are expected to slow down. That’s bad news for America’s massive housing shortage.

Construction of new homes rose 11.2% in February as builders ramped up new projects after a harsh winter. The increase is not expected to last.

Here’s how many Social Security workers are taking a buyout — so far

The Social Security Administration announced earlier this year it intended to cut its 57,000-person workforce by about 12%.

Why sportsbooks really need March Madness bettors to lose this year

March Madness numbers to know include $3.1 billion in wagers and nearly $5 million in earnings for one player.

Confidence in German economy surges as parliament approves huge spending plan

Investors welcome prospect of hundreds of billions of euros to be spent on infrastructure and defense

How good is your 401(k)? New features may help workers save more and spend better.

AI, annuity options, stickier enrollment and more comprehensive advice are setting the new standards for workplace retirement savings plans

Copper may no longer be a good economic indicator, because of Trump’s global trade war

Copper topped $5 a pound Tuesday on Comex for the first time since May, but the industrial metal’s ability to offer signals about the health of the economy has been clouded by the trade war sparked by the Trump administration’s changing tariff policies.

Industrial output jumps 0.7% in February, fueled by rebound in vehicle production

Industrial production rose 0.7% in February, the Federal Reserve reported Tuesday, above economists’ expectations.

Households plans for long-term care, but those plans may not reflect reality

For those who start with $100,000, Medicaid is not an easy option

Sarepta Therapeutics’ stock falls after patient dies of liver failure

The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.
1 718 719 720 721 722 2,697